Class II · Moderate risk
Cardec DM Drops
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
FDA Drug Recalls
1,969 recalls, newest first
Class II · Moderate risk
Cardec Drops
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Class II · Moderate risk
Brompheniramine/Pseudoephedrine Dm
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Class II · Moderate risk
Dallergy CHEWABLE TABLETS
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Class II · Moderate risk
Dallergy TABLETS
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Class II · Moderate risk
NoHist TABLETS
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Class II · Moderate risk
Ed A-Hist Tablets
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Class II · Moderate risk
Ryddex G Tablets
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Class II · Moderate risk
Ambi 40pse/400gfn
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Class II · Moderate risk
Ambi 40pse/400gfn/20dm
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Class II · Moderate risk
Ambi 3brm/30dm/50pse
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Class II · Moderate risk
Ambi 3brm/15dm/30pse
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Class II · Moderate risk
Ambi 2cpm/15dm/5peh
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Class II · Moderate risk
Ambi 25cpd/200gfn
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Class II · Moderate risk
Ambi 12.5 Cpd/120gfn/5peh
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Class II · Moderate risk
Ambi 12.5 Cpd/100gfn/30pse
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Class II · Moderate risk
Ambi 25dph/7.5peh
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Class II · Moderate risk
Ambi 20dm100gfn10peh
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Class II · Moderate risk
Ambi 15dm/100gfn/5peh
CGMP Deviations: Products are underdosed or have an incorrect dosage regime.
Class II · Moderate risk
Lansoprazole Delayed-release Capsules
Presence of Foreign Tablets/Capsules: Bottles of lansoprazole 30 mg delayed-release capsules may contain topiramate 100 mg tablets.
Class III · Low risk
Methocarbamol 750 mg Tablets
Labeling: Incorrect or missing lot and/or expiration date. The product was mistakenly labeled with an expiration date of 10/16 instead of 01/16.
Class I · High risk
Lactated Ringer's and 5% Dextrose Injection
Non-Sterility: Confirmed customer complaint of product contaminated with mold.
Class III · Low risk
Sodium Sulfacetamide 10% and Sulfur 5% Lotion
Superpotent: Drug product active ingredients were formulated incorrectly (too high) with respect to the label strength.
Class II · Moderate risk
Terazosin Hydrochloride Capsules
Presence of Foreign Tablets/Capsules: Recall is being conducted due to a foreign capsule found in one bottle.
Class III · Low risk
Crest PRO-HEALTH CPC Antigingivitis/Antiplaque Oral Rinse
Cross Contamination with Other Products: Product was mixed with another type of mouth wash.